Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

nal Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the Company's RSV vaccine program.  This grant will be used to further advance the novel pediatric RSV vaccine.
 
  • Promising data were presented on GenVec's RSV vaccine program at the 8th Annual International Respiratory Syncytial Virus Symposium, demonstrating that GenVec's pre-clinical, universal RSV vaccine candidate is highly immunogenic and produces durable and broad protection from a single intramuscular administration.  Protection in cotton rat and mouse models was characterized by functional RSV neutralizing antibodies and no disease potentiation was observed.
     
  • Encouraging preclinical proof of concept data generated in non-human primates involving GenVec's RSV vaccine program were presented at the Keystone Symposia 2012 Meeting on Viral Immunity and Host Gene Influence.  GenVec's vaccine technology induced neutralizing antibody and significant T-cell responses with a single administration.  The immune responses were consistent with protective responses without disease potentiation, and multiple administrations increased the neutralizing antibody responses.
  • HSV Vaccine

  • GenVec conducted a successful pre-IND interaction with the U.S. Food and Drug Administration (FDA) to obtain guidance on the development plan for its vaccine against herpes simplex virus (HSV).  The outcome of the pre-IND interaction was obtaining clarification on the nonclinical, clinical, and chemistry, manufacturing, and control (CMC) requirements that need to be met in order to submit an acceptable IND.
  • Data were presented on GenVec's HSV vaccine program at the Keystone Symposia meeting on Immunological Mechanisms of Vaccination.  The Company disclosed that a single administration of its genetic vaccine was effective against HSV2 in two industry-accepted HSV disease models.
  • Mala
    '/>"/>

    SOURCE GenVec, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
    2. GenVec Appoints Cynthia Collins as President and CEO
    3. GenVec Reports Inducement Award
    4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
    5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
    6. GenVec Reports Second Quarter 2012 Financial Results
    7. GenVec Reports Third Quarter 2012 Financial Results
    8. GenVec to Present at 25th Annual ROTH Conference
    9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
    10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/3/2015)... UNION CITY, Calif. , Sept. 3, 2015 /PRNewswire/ ... company manufacturing point-of-care blood instrumentation and consumables to the ... Ross Taylor , chief financial officer, will present at ... Conference 2015 on Thursday, September 10, 2015 at 11:00 ... Omni Berkshire Place Hotel in New York ...
    (Date:9/3/2015)... 03, 2015 Research and ... the "Diabetes Care Devices Market In Brazil, Russia, ... Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, ... report to their offering. The BRIC diabetes ... USD 1.7 Billion in 2015 and is poised to ...
    (Date:9/3/2015)... 3, 2015  Four financial reasons to reduce ... paper released by Leaf Healthcare, Inc . ... & Quality (AHRQ), pressure ulcers cost the ... . In addition to direct treatment related costs, ... and negatively impact hospital performance metrics. On top ...
    Breaking Medicine Technology:The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 2The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 3Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 2Four Financial Reasons to Reduce Pressure Ulcer Incidents: Leaf Healthcare Releases White Paper on Direct and Indirect Costs Associated with Pressure Ulcers 3
    ... Partners, a leading New York-based private equity firm ... and financial services companies, announced today the acquisition ... of information-based services which play an integral role ... and medical devices. WIRB is the ...
    ... DUBLIN, Ohio, Feb. 29, 2012 Earlier today the federal ... the DEA,s immediate suspension of our license to ship controlled ... this decision and have noticed our appeal of this decision ... Our contingency plans will be immediately activated, ...
    Cached Medicine Technology:Arsenal Capital Partners Announces the Acquisition of Western Institutional Review Board 2
    (Date:9/3/2015)... ... September 03, 2015 , ... Allied Anesthesia is proud to announce ... the norm not the exception. , St. Jude was recently named one of the ... Association, making it one of only 10 hospitals in the state to earn the ...
    (Date:9/3/2015)... ... 2015 , ... NanoCytomics LLC today announced the formation of ... bring low-cost cancer pre-screening tests to primary care physicians in the United States ... detects and measures cellular changes at the nanoscale level. The cellular changes have ...
    (Date:9/3/2015)... ... September 03, 2015 , ... The Oregon Collaborative for Integrative ... Health & Medicine (AIHM) Interprofessional Fellowship in Integrative Health & Medicine. The AIHM ... internationally renowned educator, physician and thought leader in integrative medicine. This is the ...
    (Date:9/3/2015)... ... 03, 2015 , ... The Beryl Institute announces 52 breakout ... held April 13-15 at Sheraton Hotel in Dallas, Texas. Patient Experience Conference is ... of healthcare leaders, staff, physicians, patients and families across the globe to convene, ...
    (Date:9/3/2015)... Rhinebeck, NY (PRWEB) , ... September 03, 2015 ... ... Kitslaar when he made the company the final destination of his six-month, 10,000 ... , During the trek—which he calls the “Connecting Las Americas” ...
    Breaking Medicine News(10 mins):Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 3Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6
    ... Impacting Physician Prescribing Patterns, ... Report from Decision Resources, WALTHAM, Mass., May 13 ... advisory firms for pharmaceutical and,healthcare issues, finds that simvastatin ... -- 22.9 percent versus 14.7,percent. Most patients progressing to ...
    ... PARSIPPANY, N.J., May 13 Ferring Pharmaceuticals Inc.,has announced ... for the pain of knee osteoarthritis, will serve as ... Babolat World Tennis Classic is a Category II United ... for men and,women aged 35-85. The largest adult tennis ...
    ... Physician executive and leader Scott Sarran embraces health ... Sarran, M.D., has,been named vice president and chief ... Illinois (BCBSIL). A seasoned physician executive with expertise,in ... care, Sarran will,be responsible for overall medical leadership; ...
    ... RELEASE, 13 May 200] Scientists at the Swedish medical ... that a receptor called ALK7 plays important roles in ... the release of insulin from beta-cells in the pancreas. ... against diabetes and obesity. , We have shown ...
    ... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... Finance, will,provide a corporate update at the upcoming Rodman ... local time on Monday, May 19,2008 at the Le ... Interested parties may access a webcast of the presentation ...
    ... FRANCISCO, May 13 Medivation, Inc.,(Nasdaq: MDVN ) today announced ... the following conferences., -- Rodman & Renshaw 5th Annual ... at 2:40 p.m. local time at Le Meridien Beach Plaza Hotel ... Specialty and Generic Pharmaceuticals Conference on Wednesday, ...
    Cached Medicine News:Health News:Simvastatin Leads Pfizer's Lipitor in Second-Line Patient Share for the Treatment of Dyslipidemia 2Health News:Simvastatin Leads Pfizer's Lipitor in Second-Line Patient Share for the Treatment of Dyslipidemia 3Health News:Ferring Pharmaceuticals' EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic 2Health News:Ferring Pharmaceuticals' EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic 3Health News:Ferring Pharmaceuticals' EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic 4Health News:Blue Cross and Blue Shield of Illinois Names New Chief Medical Officer 2Health News:Novel mechanisms controlling insulin release and fat deposition discovered 2Health News:Medivation Announces Participation in Upcoming Conferences 2
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products: